Luca Falzone
Impact in
- Cancer Research top 2%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- MicroRNA in disease regulation 20
- Cancer-related molecular mechanisms research 14
- Cancer Genomics and Diagnostics 6
- Oncology 27
- Cancer Immunotherapy and Biomarkers 10
- Co-authors
- Massimo Libra (80 shared papers)Saverio Candido (38 shared papers)Salvatore Salomone (1 shared paper)Rossella Salemi (12 shared papers)Demetrios A. Spandidos (18 shared papers)Giuseppe Gattuso (30 shared papers)Silvia Vivarelli (21 shared papers)Francesco Torino (7 shared papers)
- Journals
- The Lancet (10 papers)Cancers (9 papers)International Journal of Oncology (7 papers)International Journal of Molecular Sciences (6 papers)Nutrients (4 papers)
- Partner nations
- ItalyUnited StatesGreece
In The Last Decade
Luca Falzone
125 papers receiving 15.5k citations
Luca Falzone's Hit Papers
Peers
Comparison fields: 5 of 192
- Cancer Research 1.3k
- Oncology 1.6k
- Health, Toxicology and Mutagenesis 720
- Otorhinolaryngology 172
- Infectious Diseases 748
Countries citing papers authored by Luca Falzone
This map shows the geographic impact of Luca Falzone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Falzone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Falzone more than expected).
Fields of papers citing papers by Luca Falzone
This network shows the impact of papers produced by Luca Falzone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Falzone. The network helps show where Luca Falzone may publish in the future.
Co-authors
The 25 scholars most cited alongside Luca Falzone, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 130 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 2923 |
| 2 | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1647 |
| 3 | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 1622 |
| 4 | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 Hit paper breakdown → | 2023 | 912 |
| 5 | Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium Hit paper breakdown → | 2018 | 699 |
| 6 | Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 654 |
| 7 | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 650 |
| 8 | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 642 |
| 9 | Cutaneous melanoma: From pathogenesis to therapy (Review) Hit paper breakdown → | 2018 | 458 |
| 10 | Gut Microbiota and Cancer: From Pathogenesis to Therapy Hit paper breakdown → | 2019 | 457 |
| 11 | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 Hit paper breakdown → | 2024 | 296 |
| 12 | 2019 | 192 | |
| 13 | 2019 | 173 | |
| 14 | 2020 | 171 | |
| 15 | National-level and state-level prevalence of overweight and obesity among children, adolescents, and adults in the USA, 1990–2021, and forecasts up to 2050 Hit paper breakdown → | 2024 | 165 |
| 16 | 2018 | 134 | |
| 17 | 2022 | 133 | |
| 18 | Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Hit paper breakdown → | 2025 | 128 |
| 19 | 2020 | 127 | |
| 20 | 2017 | 121 |
About Luca Falzone
Luca Falzone is a scholar working on Cancer Research, Oncology, Molecular Biology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 130 papers that have together received 15.9k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (20 papers), Cancer-related molecular mechanisms research (14 papers), Epigenetics and DNA Methylation (11 papers), Cancer Immunotherapy and Biomarkers (10 papers), Circular RNAs in diseases (10 papers), Nutritional Studies and Diet (8 papers), Gut microbiota and health (6 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Cancer Research (1.3k citations), Oncology (1.6k citations), Health, Toxicology and Mutagenesis (720 citations), Otorhinolaryngology (172 citations) and Infectious Diseases (748 citations). Luca Falzone has collaborated with scholars based in Italy, United States and Greece. Frequent co-authors include Massimo Libra, Saverio Candido, Salvatore Salomone, Rossella Salemi, Demetrios A. Spandidos, Giuseppe Gattuso, Silvia Vivarelli, Francesco Torino, James Andrew McCubrey and Antonio Zanghì. Their work appears in journals such as The Lancet, Cancers, International Journal of Oncology, International Journal of Molecular Sciences and Nutrients.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.